BGF invests in BioCity
BGF has invested in UK-based life sciences business incubator BioCity, alongside investment firm Blue Skies Investments.
The business will use the newly secured funding to increase its provision of accelerator programmes and financial backing for resident companies. It will also enable it to extend the remit for its programmes to include earlier-stage companies.
The transaction is BGF's fourth life sciences deal since June 2018, following investments in Arcinova, Fluidic Analytics and Genedrive.
Company
Founded in 2002, Nottingham-headquartered BioCity is a life sciences business incubator. The company provides work space, access to equipment, training and guidance. It has additional centres in Glasgow and Alderley Park, Cheshire.
People
BGF – Jonathan Earl, Olly Cutting (investor).
BioCity – Glenn Crocker (chairperson).
Advisers
Equity – Browne Jacobson (legal); Claritas (tax); James Davies (financial due diligence).
Company – Geldards (legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









